AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
1.980
-0.020 (-1.00%)
At close: Mar 28, 2025, 4:00 PM
1.960
-0.020 (-1.02%)
After-hours: Mar 28, 2025, 6:00 PM EDT
AC Immune Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AC Immune stock have an average target of 12, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 506.06% from the current stock price of 1.98.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AC Immune stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +708.08% | Mar 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +708.08% | Nov 15, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +708.08% | Nov 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +708.08% | Sep 18, 2024 |
BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +304.04% | May 31, 2024 |
Financial Forecast
Revenue This Year
60.33M
from 27.31M
Increased by 120.91%
Revenue Next Year
68.67M
from 60.33M
Increased by 13.82%
EPS This Year
-0.82
from -0.51
EPS Next Year
-0.66
from -0.82
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 147.8M | 178.8M | 246.9M | ||
Avg | 60.3M | 68.7M | 118.0M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 441.3% | 196.3% | 259.6% | ||
Avg | 120.9% | 13.8% | 71.8% | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.80 | -0.63 | 0.15 | ||
Avg | -0.82 | -0.66 | 0.12 | ||
Low | -0.83 | -0.68 | 0.10 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.